Esperion Therapeutics
ESPR
#6341
Rank
C$1.13 B
Marketcap
C$4.76
Share price
-1.14%
Change (1 day)
81.50%
Change (1 year)

EPS for Esperion Therapeutics (ESPR)

EPS in 2025 (TTM): C-$0.71

According to Esperion Therapeutics's latest financial reports the company's current EPS (TTM) is C-$0.68. In 2024 the company made an earnings per share (EPS) of C-$0.31 an increase over its 2023 EPS that were of C-$2.90.

EPS history for Esperion Therapeutics from 2014 to 2025

Annual EPS

Year EPS Change
2025 (TTM)C-$0.71125.7%
2024C-$0.31-89.15%
2023C-$2.90-40.28%
2022C-$4.86-62.87%
2021C-$13.0880.38%
2020C-$7.2550.14%
2019C-$4.83-53.18%
2018C-$10.317.41%
2017C-$9.60110.81%
2016C-$4.5547.35%
2015C-$3.090.89%
2014C-$3.06

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
C$1.86-372.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
C$58.98-8,724.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
C-$8.12 1,088.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
C-$0.26-62.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
C-$0.15-78.00%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
C$3.72-644.00%๐Ÿ‡บ๐Ÿ‡ธ USA